Toyo-Oka Y, Wada C, Yamabe H, Inoue M, Ishigaki M, Matsuyama N, Ohnuki Y, Ichibe Y, Wakakura M, Ohtani H
Department of Clinical Laboratory, Kitasato University Hospital, Sagamihara, Japan.
Rinsho Byori. 1996 Jul;44(7):676-80.
Leber's hereditary optic neuropathy(LHON) is a maternally inherited mitochondrial disease of an acute or subacute bilateral loss of central vision. G to A substitutions at nucleotide position 11778 in mitochondrial DNA(mt DNA) have been identified in approximately 40% to 90% of patients. In this study, regions containing mt DNA 11778 mutations were analyzed by polymerase chain reaction(PCR), non-RI single strand conformation polymorphisms(SSCP) and direct sequencing. In 26 visually affected patients, mt DNA 11778 mutations were detected in 9 patients (36.4%). In one pedigree of a LHON patient(L-6), four unaffected family members had heteroplasmy of the 11778 mutation using non-RI SSCP. Ratios of the heteroplasmy between wild type and mutant mt DNAs can be detected in non-RI SSCP and accurately quantified by video densitometric analyzer. Two types of novel polymorphisms, 11696 G to A and 11719 A to G, in the mt DNA region were also found in this non-RI SSCP analysis. Non-RI SSCP is an efficient and accurate method for diagnosis of mt DNA 11778 mutations and quantifying heteroplasmy in patients with LHON and pedigrees.
Leber遗传性视神经病变(LHON)是一种母系遗传的线粒体疾病,表现为急性或亚急性双侧中心视力丧失。在线粒体DNA(mt DNA)核苷酸位置11778处的G到A替换已在约40%至90%的患者中被鉴定出来。在本研究中,通过聚合酶链反应(PCR)、非限制性内切酶单链构象多态性(SSCP)和直接测序对包含mt DNA 11778突变的区域进行了分析。在26例视力受影响的患者中,9例(36.4%)检测到mt DNA 11778突变。在一名LHON患者(L-6)的一个家系中,四名未受影响的家庭成员使用非限制性内切酶SSCP检测到11778突变的异质性。野生型和突变型mt DNA之间的异质性比例可在非限制性内切酶SSCP中检测到,并通过视频密度分析仪进行准确定量。在该非限制性内切酶SSCP分析中还发现了mt DNA区域的两种新型多态性,即11696 G到A和11719 A到G。非限制性内切酶SSCP是诊断LHON患者及其家系中mt DNA 11778突变和定量异质性的一种高效、准确的方法。